Clearstead Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65K | Sell |
502
-7
| -1% | -$79 | ﹤0.01% | 2066 |
|
|
2025
Q1 | $2.9K | Hold |
509
| – | – | ﹤0.01% | 1828 |
|
|
2024
Q4 | $5K | Hold |
509
| – | – | ﹤0.01% | 1716 |
|
|
2024
Q3 | $4.15K | Sell |
509
-1
| -0.2% | -$8 | ﹤0.01% | 1738 |
|
|
2024
Q2 | $6.82K | Buy |
510
+500
| +5,000% | +$6.69K | ﹤0.01% | 1624 |
|
|
2024
Q1 | $345 | Buy |
10
+2
| +25% | +$69 | ﹤0.01% | 1476 |
|
|
2023
Q4 | $507 | Sell |
8
-65
| -89% | -$4.12K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $5.3K | Buy |
73
+67
| +1,117% | +$4.86K | ﹤0.01% | 1229 |
|
|
2023
Q2 | $465 | Sell |
6
-48
| -89% | -$3.72K | ﹤0.01% | 1305 |
|
|
2023
Q1 | $2.86K | Hold |
54
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q4 | $3.63K | Hold |
54
| – | – | ﹤0.01% | 1018 |
|
|
2022
Q3 | $7K | Hold |
54
| – | – | ﹤0.01% | 926 |
|
|
2022
Q2 | $5K | Hold |
54
| – | – | ﹤0.01% | 994 |
|
|
2022
Q1 | $9K | Buy |
+54
| New | +$9K | ﹤0.01% | 995 |
|